Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Visceral Pain Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Analgesics
  • 1.3.3 Pain Modifiers
• 1.4 Market Segment by Application
  • 1.4.1 Global Visceral Pain Market Share by Application (2019-2025)
  • 1.4.2 Interstitial Cystitis
  • 1.4.3 Crohn’s
  • 1.4.4 Irritable Bowel
  • 1.4.5 Chronic Prostatitis
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Visceral Pain Market Size
  • 2.1.1 Global Visceral Pain Revenue 2014-2025
  • 2.1.2 Global Visceral Pain Sales 2014-2025
• 2.2 Visceral Pain Growth Rate by Regions
  • 2.2.1 Global Visceral Pain Sales by Regions 2014-2019
  • 2.2.2 Global Visceral Pain Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Visceral Pain Sales by Manufacturers
  • 3.1.1 Visceral Pain Sales by Manufacturers 2014-2019
  • 3.1.2 Visceral Pain Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Visceral Pain Revenue by Manufacturers (2014-2019)
  • 3.2.2 Visceral Pain Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Visceral Pain Market Concentration Ratio (CR5 and HHI)
• 3.3 Visceral Pain Price by Manufacturers
• 3.4 Key Manufacturers Visceral Pain Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Visceral Pain Market
• 3.6 Key Manufacturers Visceral Pain Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Analgesics Sales and Revenue (2014-2019)
  • 4.1.2 Pain Modifiers Sales and Revenue (2014-2019)
• 4.2 Global Visceral Pain Sales Market Share by Type
• 4.3 Global Visceral Pain Revenue Market Share by Type
• 4.4 Visceral Pain Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Visceral Pain Sales by Application

6 United States

• 6.1 United States Visceral Pain Breakdown Data by Company
• 6.2 United States Visceral Pain Breakdown Data by Type
• 6.3 United States Visceral Pain Breakdown Data by Application

7 European Union

• 7.1 European Union Visceral Pain Breakdown Data by Company
• 7.2 European Union Visceral Pain Breakdown Data by Type
• 7.3 European Union Visceral Pain Breakdown Data by Application

8 China

• 8.1 China Visceral Pain Breakdown Data by Company
• 8.2 China Visceral Pain Breakdown Data by Type
• 8.3 China Visceral Pain Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Visceral Pain Breakdown Data by Company
• 9.2 Rest of World Visceral Pain Breakdown Data by Type
• 9.3 Rest of World Visceral Pain Breakdown Data by Application
• 9.4 Rest of World Visceral Pain Breakdown Data by Countries
  • 9.4.1 Rest of World Visceral Pain Sales by Countries
  • 9.4.2 Rest of World Visceral Pain Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Pfizer
  • 10.1.1 Pfizer Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Visceral Pain
  • 10.1.4 Visceral Pain Product Introduction
  • 10.1.5 Pfizer Recent Development
• 10.2 Johnson & Johnson
  • 10.2.1 Johnson & Johnson Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Visceral Pain
  • 10.2.4 Visceral Pain Product Introduction
  • 10.2.5 Johnson & Johnson Recent Development
• 10.3 Abbvie
  • 10.3.1 Abbvie Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Visceral Pain
  • 10.3.4 Visceral Pain Product Introduction
  • 10.3.5 Abbvie Recent Development
• 10.4 Takeda
  • 10.4.1 Takeda Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Visceral Pain
  • 10.4.4 Visceral Pain Product Introduction
  • 10.4.5 Takeda Recent Development
• 10.5 Allergan
  • 10.5.1 Allergan Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Visceral Pain
  • 10.5.4 Visceral Pain Product Introduction
  • 10.5.5 Allergan Recent Development
• 10.6 AstraZeneca
  • 10.6.1 AstraZeneca Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Visceral Pain
  • 10.6.4 Visceral Pain Product Introduction
  • 10.6.5 AstraZeneca Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Visceral Pain Sales Channels
  • 11.2.2 Visceral Pain Distributors
• 11.3 Visceral Pain Customers

12 Market Forecast

• 12.1 Global Visceral Pain Sales and Revenue Forecast 2019-2025
• 12.2 Global Visceral Pain Sales Forecast by Type
• 12.3 Global Visceral Pain Sales Forecast by Application
• 12.4 Visceral Pain Forecast by Regions
  • 12.4.1 Global Visceral Pain Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Visceral Pain Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Visceral pain is pain that results from the activation of nociceptors of the thoracic, pelvic, or abdominal viscera (organs). Visceral structures are highly sensitive to distension (stretch), ischemia and inflammation, but relatively insensitive to other stimuli that normally evoke pain such as cutting or burning. Visceral pain is diffuse, difficult to localize and often referred to a distant, usually superficial, structure. It may be accompanied by symptoms such as nausea, vomiting, changes in vital signs as well as emotional manifestations. The pain may be described as sickening, deep, squeezing, and dull. Distinct structural lesions or biochemical abnormalities explain this type of pain in only a proportion of patients. These diseases are grouped under gastrointestinal neuromuscular diseases (GINMD). Others can experience visceral pains, often very intense in nature, without any evidence of structural, biochemical or histolopathologic reason for such symptoms. These diseases are grouped under functional gastrointestinal disorders (FGID) and the pathophysiology and treatment can vary greatly from GINMD. The two major single entities among functional disorders of the gut are functional dyspepsia and irritable bowel syndrome.
Growing focus on research and development by pharmaceutical companies and government initiatives are expected to boost the visceral pain industry over the forecast period. The market is projected to witness significant gain during the forecast period owing to increasing collaboration within pharmaceutical companies. Moreover, growth in the interest of scientists and researchers in studying the pain originating from internal organs has mirrored in the consciousness of the importance of visceral pain in patients. Asia Pacific is expected to grow at the highest CAGR of 6.2% from 2017 to 2024. North America has been leading the market for visceral pain, it is expected that African countries will witness exponential growth during the forecast period.
In 2019, the market size of Visceral Pain is 1020 million US$ and it will reach 1360 million US$ in 2025, growing at a CAGR of 3.7% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Visceral Pain.

This report studies the global market size of Visceral Pain, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Visceral Pain sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Pfizer
Johnson & Johnson
Abbvie
Takeda
Allergan
AstraZeneca
...

Market Segment by Product Type
Analgesics
Pain Modifiers

Market Segment by Application
Interstitial Cystitis
Crohn’s
Irritable Bowel
Chronic Prostatitis

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Visceral Pain status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Visceral Pain manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Visceral Pain are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025